Detalhe da pesquisa
1.
Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib.
Blood
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754046
2.
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Ann Hematol
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438627
3.
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.
Am J Hematol
; 99(4): 615-624, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343151
4.
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
N Engl J Med
; 383(7): 617-629, 2020 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32786187
5.
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Blood
; 137(5): 600-609, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538797
6.
Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era - real-world data from Hungary.
Ann Hematol
; 102(9): 2555-2563, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428200
7.
A potentially new thromboembolic event scoring system in polycythaemia vera patients: An audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia register.
Eur J Haematol
; 111(2): 263-270, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37203365
8.
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study.
Blood
; 135(10): 735-742, 2020 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31945149
9.
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies.
Ann Hematol
; 101(10): 2337-2345, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35836007
10.
Acalabrutinib and its use in the treatment of chronic lymphocytic leukemia.
Future Oncol
; 18(7): 755-769, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139644
11.
Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary.
Support Care Cancer
; 30(6): 5249-5258, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274189
12.
Combined prognostic role of TARC and interim 18F-FDG PET/CT in patients with Hodgkin lymphoma-real world observational study.
Hell J Nucl Med
; 25(2): 125-131, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35913858
13.
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study.
Lancet Oncol
; 22(1): 142-154, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301738
14.
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
N Engl J Med
; 378(4): 331-344, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29224502
15.
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study.
Hematol Oncol
; 39(2): 185-195, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462822
16.
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Lancet
; 393(10168): 229-240, 2019 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522922
17.
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL.
Blood
; 132(23): 2446-2455, 2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30287523
18.
Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma.
Ann Hematol
; 99(10): 2385-2392, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748163
19.
Anagrelide influences thrombotic risk, and prolongs progression-free and overall survival in essential thrombocythaemia vs hydroxyurea plus aspirin.
Eur J Haematol
; 105(4): 408-418, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32557810
20.
Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma.
Histopathology
; 74(5): 699-708, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636023